Spots Global Cancer Trial Database for childhood acute promyelocytic leukemia (m3)
Every month we try and update this database with for childhood acute promyelocytic leukemia (m3) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia | NCT00008697 | Leukemia | arsenic trioxid... | - | Washington University School of Medicine | |
| Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | NCT00021242 | Leukemia | docetaxel | - 21 Years | Children's Oncology Group | |
| Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | NCT00016159 | Leukemia | filgrastim lintuzumab arsenic trioxid... idarubicin tretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | NCT00003436 | Leukemia Myelodysplastic... | amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... | - 15 Years | National Cancer Institute (NCI) | |
| Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome | NCT00002547 | Leukemia Myelodysplastic... | busulfan cyclophosphamid... cyclosporine cytarabine methotrexate allogeneic bone... syngeneic bone ... | - 60 Years | Barbara Ann Karmanos Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia | NCT00003934 | Adult Acute Mye... Adult Acute Pro... Childhood Acute... Untreated Adult... Untreated Child... | tretinoin daunorubicin hy... cytarabine mercaptopurine methotrexate arsenic trioxid... | - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | NCT00003178 | Leukemia | filgrastim cladribine idarubicin | - 21 Years | Children's Oncology Group | |
| Tipifarnib in Treating Young Patients With Refractory Leukemia | NCT00022451 | Leukemia | tipifarnib | - 21 Years | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | NCT00003436 | Leukemia Myelodysplastic... | amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... | - 15 Years | National Cancer Institute (NCI) | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission | NCT00002609 | Leukemia | lintuzumab cytarabine idarubicin | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | NCT00005593 | Leukemia Myelodysplastic... | carboplatin fludarabine pho... topotecan hydro... | 12 Years - | Case Comprehensive Cancer Center | |
| Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia | NCT01869803 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Childhood Acute... Recurrent Adult... Recurrent Child... | gemtuzumab ozog... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | NCT00016159 | Leukemia | filgrastim lintuzumab arsenic trioxid... idarubicin tretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia | NCT00245115 | Leukemia | filgrastim busulfan cyclophosphamid... in vitro-treate... in vitro-treate... | - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia | NCT00083070 | Leukemia | temozolomide | 1 Year - 21 Years | Children's Oncology Group | |
| Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia | NCT01869803 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Childhood Acute... Recurrent Adult... Recurrent Child... | gemtuzumab ozog... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | NCT00005593 | Leukemia Myelodysplastic... | carboplatin fludarabine pho... topotecan hydro... | 12 Years - | Case Comprehensive Cancer Center | |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia | NCT00003934 | Adult Acute Mye... Adult Acute Pro... Childhood Acute... Untreated Adult... Untreated Child... | tretinoin daunorubicin hy... cytarabine mercaptopurine methotrexate arsenic trioxid... | - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
